Lanzhou Foci Pharmaceutical Co Ltd
002644
Company Profile
Business description
Lanzhou Foci Pharmaceutical Co Ltd is a pharmaceutical company based in China. The company is engaged in the production and sales of Chinese traditional medicine. In addition to manufacturing, the company also conducts research to develop new herbal drugs. Its product portfolio consists of concentrated pills, granules, hard capsules, concentrated decoctions and medicinal wine. The products of the company are exported to more than 27 countries including the United States, Canada, Japan, Australia, Russia, and Ukraine, among others.
Contact
68 Foci Street ChangGuan Region
Lanzhou730046
CHNT: +86 9318369620
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
1,362
Stocks News & Analysis
stocks
Expense concerns for ASX best idea
Expense guidance changes short-term earnings but not long-term fundamentals.
stocks
Chart of the Week: Australian asset managers face structural pressure
Read the latest take from our analysts.
stocks
Going into earnings, is Alphabet a buy, a sell, or fairly valued?
From cloud computing growth to AI monetization, here’s what we’re looking for in Alphabet’s upcoming earnings report.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,181.60 | 61.70 | -0.67% |
| CAC 40 | 8,066.68 | 86.14 | -1.06% |
| DAX 40 | 24,822.79 | 71.65 | -0.29% |
| Dow JONES (US) | 49,015.60 | 12.19 | 0.02% |
| FTSE 100 | 10,154.43 | 53.37 | -0.52% |
| HKSE | 27,826.91 | 699.96 | 2.58% |
| NASDAQ | 23,857.45 | 40.35 | 0.17% |
| Nikkei 225 | 53,463.71 | 105.00 | 0.20% |
| NZX 50 Index | 13,342.99 | 69.88 | -0.52% |
| S&P 500 | 6,978.03 | 0.57 | -0.01% |
| S&P/ASX 200 | 8,875.30 | 47.90 | -0.54% |
| SSE Composite Index | 4,151.19 | 0.05 | -0.00% |